Nutrition Status of Adults With PKU Before and During Treatment With Pegvaliase

Boston Children's Hospital

Status: Completed

Conditions: Phenylketonurias

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT03856203

IRB-P00029889

Details and patient eligibility

About

Conduct a prospective, longitudinal study to evaluate nutritional status in adults with phenylketonuria (PKU) before and during treatment with pegvaliase (Palynziq™).

Full description

The investigators will compare intra-subject change in adults with PKU who follow a protein-restricted diet (protein intake less than the RDA for protein based on weight (0.8 g/kg/day) with or without a PKU medical food) within 90 days of starting pegvaliase (baseline) and 9 and 15 months later. The investigators will collect laboratory measures of nutrition status, anthropometrics, Dual-Energy X-Ray Absorptiometry (DXA) to measure body composition and bone mineral density (BMD), and indirect calorimetry to measure resting energy expenditure (REE). In addition, three-day food records will be obtained to assess protein intake and overall diet quality.

Enrollment: 12 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of phenylketonuria
• Aged 18-65 years
• Following a protein-restricted diet with or without medical food within the last 30 days
• Routine natural protein intake from food is less than the RDA for protein based on weight (0.8 g/kg/day).
• If not consuming animal proteins, recommended protein intake is 115% RDA due to lower bioavailability of plant proteins.
• Within ±90 days of starting treatment with pegvaliase at time of study enrollment

Exclusion criteria

• Unable to consent to study
• Under age 18 or over age 65 years
• Routine natural protein intake is greater than the RDA for protein (0.8 g/kg/d) within the last 30 days.
• Females who are currently pregnant or lactating